ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 1344

Diagnostic Value of High Sensitivity C Reactive Protein for Early Axial Spondyloarthritis: Results From the Devenir Des Spondylarthopathies Indifferenciees Recentes Cohort

Victoria Navarro-Compán1, Désirée van der Heijde2, Bernard Combe3, Claudine Cosson4 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Deptartment of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Rheumatology, Hopital Lapeyronie, Montpellier, France, 4Biochemistry, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Paris, France

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: C-reactive protein (CRP), diagnosis and spondylarthropathy

Session Information

Title: Spondylarthropathies and Psoriatic Arthritis: Clinical Aspects and Treatment

Session Type: Abstract Submissions (ACR)

Background/Purpose: The average delay in spondyloarthritis (SpA) diagnosis after symptom onset is one of the longest among the inflammatory rheumatic diseases. Elevated C-reactive protein (CRP) has been incorporated as one of the features for ASAS axial SpA criteria and in the Berlin diagnostic algorithm. However, CRP levels are elevated in only a minority of early SpA patients which limits its potential diagnostic value. More sensitive tests called high-sensitivity CRP (hsCRP) have been developed and can detect lower concentrations of CRP compared with traditional methods. Therefore, hsCRP could be more sensitive than traditional CRP for diagnosis in axial SpA. The aim of this study was to assess if hsCRP measurement contributes to early axial SpA diagnosis compared with traditional CRP measurement.

Methods: Baseline data from 648 patients with inflammatory back pain (IBP) duration >3 months but <3 years from DESIR cohort was used. Design and inclusion criteria have previously been reported (1). Levels of CRP and hsCRP were measured in serum at baseline. The cut-off values selected to define positive hsCRP and CRP were ≥ 2 mg/l and ≥ 5mg/l, respectively.

 

Results: Based on the ASAS axial SpA criteria, 444 (69%) patients were classified as SpA and 203 (31%) patients as no SpA. Patients’ characteristics and lab results are shown in table 1. Serum levels of CRP and hsCRP were higher in SpA versus no SpA. In the subgroup of patients with a negative CRP, mean serum levels of hsCRP were also higher in SpA patients compared with no SpA patients (1.7 mg/L vs 1.5 mg/L, p 0.03). Moreover, after dichotomizing hsCRP, more patients within the SpA group had a positive hsCRP versus the no SpA group, although this difference was not statistically significant (p=0.06) (table 2). 

 

Finally, we investigated how many extra patients from the no SpA group (n=203) would be classified as SpA substituting the traditional CRP by hsCRP in the clinical arm (HLA-B27 arm) of the ASAS axial SpA criteria. Only 4 (2%) extra patients had 2 axial SpA features instead of only 1 feature (IBP) substituting hsCRP by CRP (195 vs 191 patients), but none of them was HLA-B27 positive. Consequently, none of the no SpA patients met ASAS criteria applying this modification.

Conclusion: In patients with a normal CRP, hsCRP is increased in axial SpA patients compared with patients without SpA. However, hsCRP measurement in patients with IBP may not add any extra value for early axial SpA diagnose compared with CRP measured by traditional method.

 

(1) Dougados M et al. Joint Bone Spine. 2011 Dec;78(6):598-603.

 

 

Table 1: Characteristics of patients

 

 

 

SpA

n=444 (69%)

No SpA

n=203 (31%)

P value

 Age (years)             

32.4 ± 8.6

34.8 ± 8.3

0.001

 Male

223 (50%)

76 (37%)

0.01

 Caucasoid

400 (90%)

159 (88%)

0.5

 Back pain duration

1.0 ± 0.9

0.9 ± 8.4

0.03

 HLA-B27 positive

368 (83%)

8 (4%)

<0.0001

 Sacroiliitis on MRI

106 (52%)

0 (0%)

<0.0001

 Sacroiliitis on X-Ray

107 (24%)

0 (0%)

<0.0001

 CRP (mg/L)

3.9 (1-8.6)

2.6 (1-5)

<0.0001

 

 

 

 

 hsCRP (mg/L)

2.8 (1.1-8.1)

1.6 (0.3-3.6)

<0.0001

 

 

Table 2: Serum levels of hs-CRP in patients with normal CRP values (<5 mg/L)

 

 hsCRP

SpA

(n=260)

No SpA

(n=152)

 <2          

174 (66.9%)

110 (72.4%)

 ≥2 – <3

41 (15.8%)

30 (19.7%)

 ≥3 – <4

34 (13.1%)

11 (7.2%)

 ≥4 – <5

7 (2.7%)

0

 ≥ 5

4 (1.5%)

1 (0.7%)

 

 


Disclosure:

V. Navarro-Compán,
None;

D. van der Heijde,
None;

B. Combe,
None;

C. Cosson,
None;

F. van Gaalen,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/diagnostic-value-of-high-sensitivity-c-reactive-protein-for-early-axial-spondyloarthritis-results-from-the-devenir-des-spondylarthopathies-indifferenciees-recentes-cohort/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology